DexCom
DXCM
794 hedge funds and large institutions have $29.9B invested in DexCom in 2022 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 290 increasing their positions, 309 reducing their positions, and 72 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
8% more capital invested
Capital invested by funds: $27.6B → $29.9B (+$2.31B)
10% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 72
0.41% more ownership
Funds ownership: 94.36% → 94.76% (+0.41%)
0% less funds holding
Funds holding: 797 → 794 (-3)
6% less repeat investments, than reductions
Existing positions increased: 290 | Existing positions reduced: 309
18% less call options, than puts
Call options by funds: $324M | Put options by funds: $398M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$311M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$279M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$241M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$128M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$205M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
-$185M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$161M |
| 4 |
Jennison Associates
New York
|
-$137M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$102M |
DXCM Hedge Fund Activity: Q3 2022 in Review
794 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2022, worth a combined $29.9B — up 8.4% from $27.6B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new DXCM positions and 72 closed out — a net gain of 7 holders — while 290 added to existing stakes and 309 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $311M. The largest seller was Citadel Advisors, cutting an estimated $205M.
- 794 institutional investors held DexCom (DXCM) as of Q3 2022, down from 797 in Q2 2022.
- Funds reported $29.9B of DexCom stock for Q3 2022, up 8.4% quarter-over-quarter.
- 79 funds opened new DexCom positions in Q3 2022 and 72 closed out, a net change of +7 holders.
- The largest DexCom buyer in Q3 2022 was Janus Henderson Group, an estimated $311M added.
- The largest DexCom seller in Q3 2022 was Citadel Advisors, an estimated $205M sold.
Based on aggregated 13F filings for Q3 2022.